Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Mechanism TYR modulators(Tyrosinase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H33N5O7 |
InChIKeyICPRUPYAABXYEY-LROBGIAVSA-N |
CAS Registry2764624-90-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperpigmentation | Preclinical | CN | 01 Dec 2021 | |
Melanoma | Preclinical | CN | 01 Dec 2021 |